Acute lymphoblastic leukemia in pregnancy: a case report with literature review

The management of acute lymphoblastic leukemia (ALL) during pregnancy requires treatment with high-dose chemotherapy that can pose risks to both the mother and fetus. Special consideration to chemotherapy regimen and its doses and to fetal gestational age at the time of chemotherapy administration s...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic advances in hematology Vol. 4; no. 5; pp. 313 - 319
Main Authors Ticku, Jonathan, Oberoi, Shilpa, Friend, Sarah, Busowski, John, Langenstroer, Mary, Baidas, Said
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.10.2013
Subjects
Reviews
Leukemia
pregnancy
Online AccessGet full text

Cover

More Information
Summary:The management of acute lymphoblastic leukemia (ALL) during pregnancy requires treatment with high-dose chemotherapy that can pose risks to both the mother and fetus. Special consideration to chemotherapy regimen and its doses and to fetal gestational age at the time of chemotherapy administration should be taken in order to limit fetal exposure while still providing optimal therapy to the mother. Here we describe a 22-year-old patient who was diagnosed at 26 weeks gestation with ALL and was treated in the third trimester with HyperCVAD (cytoxan, vincristine, adriamycin, dexamethasone) combination chemotherapy giving birth via Caesarean section to a healthy baby girl 4 weeks after induction chemotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2040-6207
2040-6215
DOI:10.1177/2040620713492933